Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons.
about
Cryptosporidium pathogenicity and virulenceCryptosporidium in humans and animals-a one health approach to prophylaxis.Burden of disease from cryptosporidiosis.Initial data on the molecular epidemiology of cryptosporidiosis in Lebanon.Cryptosporidium spp., Giardia duodenalis, Enterocytozoon bieneusi and other intestinal parasites in young children in Lobata province, Democratic Republic of São Tomé and Principe.Comparison of single- and multilocus genetic diversity in the protozoan parasites Cryptosporidium parvum and C. hominis.Public health significance of zoonotic Cryptosporidium species in wildlife: Critical insights into better drinking water management.Identification of a high diversity of Cryptosporidium species genotypes and subtypes in a pediatric population in Nigeria.Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.High applicability of a novel method for gp60-based subtyping of Cryptosporidium meleagridisGenomics and population biology of Cryptosporidium species.Cryptosporidiosis in HIV/AIDS patients in Kenya: clinical features, epidemiology, molecular characterization and antibody responses.Global distribution, public health and clinical impact of the protozoan pathogen cryptosporidiumGuidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theDetection and differentiation of Cryptosporidium spp. in human clinical samples by use of real-time PCRA multi-locus study of cryptosporidium parasites isolated from patients living in iran, Malawi, Nigeria, the United kingdom, and Vietnam.Evaluation of four commercial rapid immunochromatographic assays for detection of Cryptosporidium antigens in stool samples: a blind multicenter trialOccurrence, source, and human infection potential of cryptosporidium and Giardia spp. in source and tap water in shanghai, china.Epidemiology and molecular characterization of Cryptosporidium spp. in humans, wild primates, and domesticated animals in the Greater Gombe Ecosystem, Tanzania.Cryptosporidium meleagridis: infectivity in healthy adult volunteers.Distribution and clinical manifestations of Cryptosporidium species and subtypes in HIV/AIDS patients in Ethiopia.Molecular characterization of Cryptosporidium spp. among children in rural Ghana.Molecular characterization of Cryptosporidium spp. in children from Mexico.Cases of cryptosporidiosis co-infections in AIDS patients: a correlation between clinical presentation and GP60 subgenotype lineages from aged formalin-fixed stool samples.Rapid microfluidic immunoassay for surveillance and diagnosis of Cryptosporidium infection in human immunodeficiency virus-infected patients.High diversity of Cryptosporidium subgenotypes identified in Malaysian HIV/AIDS individuals targeting gp60 gene.Genetic Diversity of Cryptosporidium in Children in an Urban Informal Settlement of Nairobi, KenyaCryptosporidiosis-an overview.Revisiting the reference genomes of human pathogenic Cryptosporidium species: reannotation of C. parvum Iowa and a new C. hominis reference.Genetic diversity of Cryptosporidium identified in clinical samples from cities in Brazil and ArgentinaGeographic linkage and variation in Cryptosporidium hominisCryptosporidium species and subtypes and clinical manifestations in children, PeruMulticentric evaluation of a new real-time PCR assay for quantification of Cryptosporidium spp. and identification of Cryptosporidium parvum and Cryptosporidium hominisUnusual Enterocytozoon bieneusi genotypes and Cryptosporidium hominis subtypes in HIV-infected patients on highly active antiretroviral therapy.Treatment of parasitic diarrhea in HIV-infected patients.Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.Assessment of Giardia and Cryptosporidium spp. as a microbial source tracking tool for surface water: application in a mixed-use watershed.Cryptosporidiosis: environmental, therapeutic, and preventive challenges.Prevalence, Clinical Manifestations and Genotyping of Cryptosporidium Spp. in Patients with Gastrointestinal Illnesses in Western Iran.Predominance of Cryptosporidium parvum genotype among diarrheic children from Egypt as an indicator for zoonotic transmission.
P2860
Q26823336-52550044-0121-4975-801C-801427F8EDABQ30248799-24653AC5-6EA1-4270-BCDC-720632E4CD73Q30384769-281BD269-D551-47CD-ACDD-5B6D2B3B1348Q30946092-DF02B7DA-076B-4FB9-B8E0-91226F9423FDQ33638381-8412300C-7651-4E87-A1DB-BB219915B2F4Q33658275-11AD3896-670B-4F40-A3A2-1E9DC941574CQ33712329-D1FB0EEE-3EC7-4DE7-9110-76FB8F930B15Q33749757-F6319CC7-3198-4E02-87EF-E96D21E6492EQ33768898-A47B82BC-82F9-43A4-88B0-B99E1B5F421FQ33899883-3FA46A24-5CD3-46C8-AD5A-BE20B38EFBF4Q33905799-99C99E9E-5DDB-4CE9-9F97-7A345EEA4C08Q34015942-8BD88C0B-BED2-4D14-9A49-C6B66456E568Q34034600-8AE6573F-56F0-4381-B94E-63F2CB40422FQ34212799-0CF52D44-18B4-4661-AB26-2AE1EF29362DQ34741457-139F8D22-760E-4F79-82A3-2BBAB2B7DA72Q34905875-7D8F4514-6552-496F-BC85-2EF30FE27AE5Q35067112-876B09AD-E6C4-4EE8-855D-4AB9DD4CAD4BQ35080783-0188A136-A3C7-4AB5-B12C-75A86EA3EFBCQ35107141-E9FF2DE5-6CA3-4ED5-8D74-A8994C2FE6ECQ35131374-F816CE92-A456-4893-9278-F5026935B6E4Q35151910-B76D8E6C-769E-4750-9212-B460553185FAQ35154654-970020A3-5EED-4D52-B31B-6B3B6C8A5F9BQ35154851-3F367735-2D9B-4657-800C-EBC64379799AQ35222537-957413E5-E649-4211-8C7F-EE90030D7ACFQ35465690-DD6CE189-6D5D-4E21-ABD3-29CC6BDA374DQ35745036-116D24D5-88A5-44DE-87C9-50839E0AC007Q35874801-94A8EDF0-7526-42B0-A682-176EF6B4B321Q36012004-AC167FF8-C75E-4EE6-B229-393B1DFFF98EQ36262448-370767CE-B5AA-4032-9B9C-AE8FAEC0FF2CQ36503864-E7BF4925-7770-49B2-98BE-104AFBEB71A9Q36944709-1DCBB149-B1AA-4C5E-80B4-7AD70C23F6A8Q37028494-26245F0E-D4EC-444F-AA51-DB454778FF43Q37036232-7B3BA81B-7CD4-4016-8A5B-7CA544FAE856Q37107937-7EA2FF5C-21EA-4C4F-9B23-BB10E6FA1AA1Q37202848-8F36623C-AE5D-46DC-8598-C03544E621F2Q37712806-9D0CC1F3-28F5-4B9D-8DD5-6FB17D8F968CQ37712929-D1CE62B5-3A48-441C-A49D-4481FD3AB6A2Q37762488-E2BD9D6C-D666-4F68-B771-C8E30B66570AQ38650544-EF15B189-7123-43B8-9090-9A4753C9436AQ38994431-02E8A6A0-65E9-4C6B-8000-FD32FF4A13E6
P2860
Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Differences in clinical manife ...... types in HIV-infected persons.
@en
Differences in clinical manife ...... types in HIV-infected persons.
@nl
type
label
Differences in clinical manife ...... types in HIV-infected persons.
@en
Differences in clinical manife ...... types in HIV-infected persons.
@nl
prefLabel
Differences in clinical manife ...... types in HIV-infected persons.
@en
Differences in clinical manife ...... types in HIV-infected persons.
@nl
P2093
P50
P356
P1476
Differences in clinical manife ...... types in HIV-infected persons.
@en
P2093
Aldo Vivar
Daniel Vargas
Jennifer M Ross
John Williamson
Marco Navincopa
Sara Crawford
Vitaliano A Cama
Vivian Kawai
Ynes Ortega
P304
P356
10.1086/519842
P407
P577
2007-07-13T00:00:00Z